Blockbuster drug Humira finally faces lower-cost rivals
After years of being the world's best-selling drug, Humira faces competition from copycat versions known as biosimilars. One called Yusimry costs a $1,000 or less.
Source: wsiu.org
📰 Chris Slavinsky News
Chris Slavinsky News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chris Slavinsky. Real-time updates on events, politics, business and more.
Yusimry's bargain price could give it an edge over Humira : Shots
After years of being the world's best-selling drug, Humira faces competition from copycat versions known as biosimilars. One called Yusimry costs a $1,000 or less.
Source: npr.org
Blockbuster drug Humira finally faces lower-cost rivals
After years of being the world's best-selling drug, Humira faces competition from copycat versions known as biosimilars. One called Yusimry costs a $1,000 or less.
Source: wpsu.org
SmithRx to Offer Adalimumab Biosimilar Yusimry at 90% Discount to Humira
The pharmacy benefit manager SmithRx has announced that through a partnership with the Mark Cuban Cost Plus Drug Company, it will offer Yusimry, an adalimumab biosimilar, for less than 90% of the cost of the reference product, Humira.
Source: ajmc.com
Cheapest Humira alternative to be available in July | Crain's Chicago Business
Coherus BioSciences has struck a deal with billionaire Mark Cuban’s Cost Plus Drug Co. to get the product to patients starting in July.
Abbvie Humira Chris Slavinsky Denny Lanfear Mark Cuban Cost Plus Drug Co Amgen Inc California Based Coherus
Source: chicagobusiness.com